Exact Mass: 357.1094

Exact Mass Matches: 357.1094

Found 97 metabolites which its exact mass value is equals to given mass value 357.1094, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Deacetoxycephalosporin C

Deacetoxycephalosporin C; DAOC

C14H19N3O6S (357.0995)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

cyclo-dopa 5-O-glucoside

(2S)-6-hydroxy-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

C15H19NO9 (357.106)


Cyclo-dopa 5-o-glucoside, also known as leucodopachrome 5-beta-D-glucoside, is a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Cyclo-dopa 5-o-glucoside is soluble (in water) and a moderately acidic compound (based on its pKa). Cyclo-dopa 5-o-glucoside can be found in a number of food items such as almond, gooseberry, apricot, and pepper (c. pubescens), which makes cyclo-dopa 5-o-glucoside a potential biomarker for the consumption of these food products.

   

deoxyviolaceinic acid

deoxyviolaceinic acid

C21H15N3O3 (357.1113)


A pyrrolecarboxylic acid that is pyrrole-2-carboxylic acid which is substituted at position 3 by a 3-hydroxyindol-3-yl group at at position 5 by an indol-3-yl group.

   

protoviolaceinic acid

protoviolaceinic acid

C21H15N3O3 (357.1113)


   

Rosiglitazone

5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate

C18H19N3O3S (357.1147)


Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFκB) levels fall and inhibitor (IκB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes; Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. It is being marketed as Avandia by the pharmaceutical company GlaxoSmithKline, both as a standalone preparation and in combination with metformin (Avandamet). Another combination drug approved by the FDA is Avandaryl (with glimepiride); Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFkB) levels fall and inhibitor (IkB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes . [HMDB] Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha-binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFκB) levels fall and inhibitor (IκB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes; Rosiglitazone is an anti-diabetic drug from the thiazolidinedione class. It is being marketed as Avandia by the pharmaceutical company GlaxoSmithKline, both as a standalone preparation and in combination with metformin (Avandamet). Another combination drug approved by the FDA is Avandaryl (with glimepiride); Like other thiazolidinediones, its mechanism of action is by activation of the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPAR-gamma. Rosiglitazone is a pure ligand of PPAR-gamma, and has no PPAR-alpha binding action. Apart from its effect on insulin resistance, it appears to have an anti-inflammatory effect: nuclear factor kappa-B (NFkB) levels fall and inhibitor (IkB) levels increase in patients on rosiglitazone (Mohanty et al). It increases glyceroneogenesis and reduces the release of free fatty acids from adipocytes. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

   

HMBOA-Glc

7-methoxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C15H19NO9 (357.106)


Constituent of the roots of Coix lachryma-jobi (Jobs tears). (R)-2-Hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one 2-glucoside is found in many foods, some of which are coffee and coffee products, corn, alcoholic beverages, and tea. HMBOA-Glc is found in alcoholic beverages. HMBOA-Glc is a constituent of the roots of Coix lachryma-jobi (Jobs tears).

   

Cyclodopa glucoside

6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

C15H19NO9 (357.106)


Cyclodopa glucoside is found in brassicas. Cyclodopa glucoside occurs in red beet cabbage juic

   

2-Methoxyacetaminophen glucuronide

(2S,3S,4S,5R,6S)-6-(4-acetamido-3-methoxyphenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H19NO9 (357.106)


2-Methoxyacetaminophen glucuronide is classified as a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 2-Methoxyacetaminophen glucuronide is considered to be soluble (in water) and a moderately acidic compound.

   

[3H]Rosiglitazone

4-hydroxy-5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-2,3-dihydro-1,3-thiazol-2-one

C18H19N3O3S (357.1147)


   

2-(Bis(2-(2,6-dioxomorpholino)ethyl)amino)acetic acid

2-{bis[2-(2,6-dioxomorpholin-4-yl)ethyl]amino}acetic acid

C14H19N3O8 (357.1172)


   

Bendamustine

4-{5-[bis(2-chloroethyl)amino]-1-methyl-1H-1,3-benzodiazol-2-yl}butanoic acid

C16H21Cl2N3O2 (357.1011)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents

   
   

O1-[(3,5-Dimethyl-4-isoxazolyl)carbonyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide

O1-[(3,5-Dimethyl-4-isoxazolyl)carbonyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanehydroximamide

C16H15N5O5 (357.1073)


   

({[Benzyl(2-cyanoethyl)amino]carbonyl}amino)(4-methylphenyl)dioxo-λ6-sulfane

({[Benzyl(2-cyanoethyl)amino]carbonyl}amino)(4-methylphenyl)dioxo-λ6-sulfane

C18H19N3O3S (357.1147)


   
   

8-O-beta-D-glucopyranoside of 8-hydroxy-2-quinolone-4-carboxylic acid

8-O-beta-D-glucopyranoside of 8-hydroxy-2-quinolone-4-carboxylic acid

C15H19NO9 (357.106)


   
   

Chromoazepinone C

Chromoazepinone C

C21H15N3O3 (357.1113)


   

Trigonostemine D

Trigonostemine D

C21H15N3O3 (357.1113)


   

Trigonostemine C

Trigonostemine C

C21H15N3O3 (357.1113)


   

Chromoazepinone A

Chromoazepinone A

C21H15N3O3 (357.1113)


   

rosiglitazone

5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, monopotassium salt

C18H19N3O3S (357.1147)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

   

C15H19NO9_2H-1,4-Benzoxazin-3(4H)-one, 2-(beta-D-glucopyranosyloxy)-7-methoxy-, (2R)

NCGC00385508-01_C15H19NO9_2H-1,4-Benzoxazin-3(4H)-one, 2-(beta-D-glucopyranosyloxy)-7-methoxy-, (2R)-

C15H19NO9 (357.106)


   
   

HMBOA + O-Hex

HMBOA + O-Hex

C15H19NO9 (357.106)


Annotation level-3

   

1,N2-Benzoquinone-deoxyguanosine

1,N2-Benzoquinone-deoxyguanosine

C16H15N5O5 (357.1073)


   

Bendamustine

Bendamustine

C16H21Cl2N3O2 (357.1011)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01A - Alkylating agents > L01AA - Nitrogen mustard analogues D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D009676 - Noxae > D000477 - Alkylating Agents

   

Cyclodopa glucoside

6-hydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1H-indole-2-carboxylic acid

C15H19NO9 (357.106)


   

2-Gmbo

7-methoxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C15H19NO9 (357.106)


   

Etibendazole

Carbamic acid,N-[6-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]-1H-benzimidazol-2-yl]-, methylester

C18H16FN3O4 (357.1125)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

2,4,6-Triphenoxy-1,3,5-triazine

2,4,6-Triphenoxy-1,3,5-triazine

C21H15N3O3 (357.1113)


   
   
   

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-[3-(trifluoromethyl)benzoyl]- (9CI)

Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-[3-(trifluoromethyl)benzoyl]- (9CI)

C19H14F3N3O (357.1089)


   

3-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]benzoic acid

3-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]benzoic acid

C19H19NO4S (357.1035)


   

Fmoc-cys(me)-oh

Fmoc-cys(me)-oh

C19H19NO4S (357.1035)


   

10-(2-chloroethyl)-6-piperazin-1-ylbenzo[b][1,4]benzothiazepine

10-(2-chloroethyl)-6-piperazin-1-ylbenzo[b][1,4]benzothiazepine

C19H20ClN3S (357.1066)


   

N-(3-NITRO-2-PYRIDINESULFENYL)-L-GLUTAMIC ACID GAMMA-T-BUTYL ESTER

N-(3-NITRO-2-PYRIDINESULFENYL)-L-GLUTAMIC ACID GAMMA-T-BUTYL ESTER

C14H19N3O6S (357.0995)


   

4-hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxoquinoline-3-carboxamide

4-Hydroxy-1-isobutyl-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihy dro-3-quinolinecarboxamide

C18H19N3O3S (357.1147)


   

2-CHLORO-3-NITROBENZOICACID

2-CHLORO-3-NITROBENZOICACID

C15H16BF4N3S (357.1094)


   

N,N-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide

N,N-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide

C14H19N3O8 (357.1172)


   

2-bromo-9-octyl-9H-carbazole

2-bromo-9-octyl-9H-carbazole

C20H24BrN (357.1092)


   

5-(2-benzothiazolyl)-1,3-diphenylformazan

5-(2-benzothiazolyl)-1,3-diphenylformazan

C20H15N5S (357.1048)


   

2-Biphenyl-4-yl-6-fluoro-3-methyl-quinoline-4-carboxylic acid

2-Biphenyl-4-yl-6-fluoro-3-methyl-quinoline-4-carboxylic acid

C23H16FNO2 (357.1165)


   

Piperidine, 4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)-, hydrochloride (1:1)

Piperidine, 4-(2-((2,4,6-trifluorophenoxy)methyl)phenyl)-, hydrochloride (1:1)

C18H19ClF3NO (357.1107)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-Methoxyacetaminophen glucuronide

3-Methoxyacetaminophen glucuronide

C15H19NO9 (357.106)


   

(+)-Rosiglitazone

(+)-Rosiglitazone

C18H19N3O3S (357.1147)


   

Rosiglitazone, (S)-

Rosiglitazone, (S)-

C18H19N3O3S (357.1147)


   
   

4-[[2-(Phenylmethyl)-1-benzimidazolyl]sulfonyl]morpholine

4-[[2-(Phenylmethyl)-1-benzimidazolyl]sulfonyl]morpholine

C18H19N3O3S (357.1147)


   

3-[[2-(4-Fluorophenoxy)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

3-[[2-(4-Fluorophenoxy)-1-oxoethyl]amino]-2-benzofurancarboxylic acid ethyl ester

C19H16FNO5 (357.1012)


   

1,3,5-Triphenyl-1,3,5-triazinane-2,4,6-trione

1,3,5-Triphenyl-1,3,5-triazinane-2,4,6-trione

C21H15N3O3 (357.1113)


   

Ethyl 5-[2-(mesitylamino)-1,3-thiazol-4-yl]isoxazole-3-carboxylate

Ethyl 5-[2-(mesitylamino)-1,3-thiazol-4-yl]isoxazole-3-carboxylate

C18H19N3O3S (357.1147)


   

Cellobionate

Cellobionate

C12H21O12- (357.1033)


A carbohydrate acid anion that is the conjugate base of cellobionic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

O-Phosphono-N-(8-Sulfanyloctanoyl)-L-Threonine

O-Phosphono-N-(8-Sulfanyloctanoyl)-L-Threonine

C12H24NO7PS (357.1011)


   
   

10-Deoxygeniposidate

10-Deoxygeniposidate

C16H21O9- (357.1186)


   

4-O-methyl-DIBOA-glucoside

4-O-methyl-DIBOA-glucoside

C15H19NO9 (357.106)


   

(7R)-7-[[(5R)-5-amino-5-carboxypentanoyl]amino]-3-methylidene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic acid

(7R)-7-[[(5R)-5-amino-5-carboxypentanoyl]amino]-3-methylidene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic acid

C14H19N3O6S (357.0995)


   

2-Methoxyacetaminophen glucuronide

2-Methoxyacetaminophen glucuronide

C15H19NO9 (357.106)


A beta-D-glucosiduronic acid that is 2-methoxyacetaminophen in which the phenolic hydrogen is replaced by a beta-D-glucuronosyl group.

   

HMBOA D-glucoside

HMBOA D-glucoside

C15H19NO9 (357.106)


   

1-(4-Ethoxyphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea

1-(4-Ethoxyphenyl)-3-(4-methyl-3-oxo-1,4-benzothiazin-6-yl)urea

C18H19N3O3S (357.1147)


   

4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide

4-methoxy-N-[4-[[(1-oxopropylamino)-sulfanylidenemethyl]amino]phenyl]benzamide

C18H19N3O3S (357.1147)


   

4-(4-Methoxyanilino)-2,5-dimethyl-6-thieno[2,3-d]pyrimidinecarboxylic acid ethyl ester

4-(4-Methoxyanilino)-2,5-dimethyl-6-thieno[2,3-d]pyrimidinecarboxylic acid ethyl ester

C18H19N3O3S (357.1147)


   

N-[3-[[2-furanyl(oxo)methyl]amino]phenyl]-1-isoquinolinecarboxamide

N-[3-[[2-furanyl(oxo)methyl]amino]phenyl]-1-isoquinolinecarboxamide

C21H15N3O3 (357.1113)


   
   

N(6)-(3-O-phospho-D-ribulosyl)-L-lysine

N(6)-(3-O-phospho-D-ribulosyl)-L-lysine

C11H22N2O9P- (357.1063)


   

4-hydroxy-1-(2-methylpropyl)-N-(4-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

4-hydroxy-1-(2-methylpropyl)-N-(4-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

C18H19N3O3S (357.1147)


   

3-aminopropyl N-acetyl-alpha-D-glucosamine-1-phosphate(1-)

3-aminopropyl N-acetyl-alpha-D-glucosamine-1-phosphate(1-)

C11H22N2O9P- (357.1063)


   

2alpha-(beta-D-Glucopyranosyloxy)-7-methoxy-2H-1,4-benzooxazine-3(4H)-one

2alpha-(beta-D-Glucopyranosyloxy)-7-methoxy-2H-1,4-benzooxazine-3(4H)-one

C15H19NO9 (357.106)


   

2-Amino-3-[(3-hexanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

2-Amino-3-[(3-hexanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C12H24NO9P (357.1189)


   

cyclo-dopa 5-O-glucoside

cyclo-dopa 5-O-glucoside

C15H19NO9 (357.106)


   
   

HMBOA beta-D-glucoside

HMBOA beta-D-glucoside

C15H19NO9 (357.106)


A beta-D-glucoside derived from 2-hydroxy-7-methoxy-3-oxo-3,4-dihydro-2H-1,4-benzoxazine.

   

cyclodopa 5-beta-D-glucoside

cyclodopa 5-beta-D-glucoside

C15H19NO9 (357.106)


An indolyl carbohydrate that is cyclodopa in which the phenolic hydrogen at position 5 has been replaced by a beta-D-glucosyl residue.

   
   

6-[9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20ClNO3 (357.1132)


   

(6r,7r)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H19N3O6S (357.0995)


   

14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol

14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-7,12-diol

C21H15N3O3 (357.1113)


   

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-2-ol

3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-2-ol

C21H15N3O3 (357.1113)


   

6-methoxy-3-{9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-2-ol

6-methoxy-3-{9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indol-2-ol

C21H15N3O3 (357.1113)


   

2-hydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3a,7a-dihydro-3h-indole-3-carboxylic acid

2-hydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3a,7a-dihydro-3h-indole-3-carboxylic acid

C15H19NO9 (357.106)


   

2-[(3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C15H19NO9 (357.106)


   

(6r,7s)-7-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7s)-7-{[(5s)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H19N3O6S (357.0995)


   

4-(1h-indol-3-yl)-5-oxo-3h,4h,6h-azepino[4,5-b]indole-2-carboxylic acid

4-(1h-indol-3-yl)-5-oxo-3h,4h,6h-azepino[4,5-b]indole-2-carboxylic acid

C21H15N3O3 (357.1113)


   

4-hydroxy-5-(1h-indol-3-yl)-5h,6h-azepino[4,5-b]indole-2-carboxylic acid

4-hydroxy-5-(1h-indol-3-yl)-5h,6h-azepino[4,5-b]indole-2-carboxylic acid

C21H15N3O3 (357.1113)


   

(2r,3r,4s,5s,6s)-2-{[(2r)-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{[(2r)-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H19NO9 (357.106)


   

(4r)-4-(1h-indol-3-yl)-5-oxo-3h,4h,6h-azepino[4,5-b]indole-2-carboxylic acid

(4r)-4-(1h-indol-3-yl)-5-oxo-3h,4h,6h-azepino[4,5-b]indole-2-carboxylic acid

C21H15N3O3 (357.1113)


   

14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

C21H15N3O3 (357.1113)


   

(3s,3as,7ar)-2-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3a,7a-dihydro-3h-indole-3-carboxylic acid

(3s,3as,7ar)-2-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3a,7a-dihydro-3h-indole-3-carboxylic acid

C15H19NO9 (357.106)


   

(5r)-4-hydroxy-5-(1h-indol-3-yl)-5h,6h-azepino[4,5-b]indole-2-carboxylic acid

(5r)-4-hydroxy-5-(1h-indol-3-yl)-5h,6h-azepino[4,5-b]indole-2-carboxylic acid

C21H15N3O3 (357.1113)


   

7-[(5-amino-5-carboxy-1-hydroxypentylidene)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

7-[(5-amino-5-carboxy-1-hydroxypentylidene)amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C14H19N3O6S (357.0995)


   

6-[(2z,4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[(2z,4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20ClNO3 (357.1132)


   

(14r)-14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

(14r)-14-methoxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaene-6,12-diol

C21H15N3O3 (357.1113)


   

6-[(2e,4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[(2e,4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20ClNO3 (357.1132)


   

(2s,3r,4s,5s,6r)-2-{[(2s)-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H19NO9 (357.106)


   

6-[(4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

6-[(4e,6e,8e)-9-(3-chloro-1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]-4-methoxy-3-methylpyran-2-one

C20H20ClNO3 (357.1132)